Carna Health, Siemens Healthineers Partner on AI-Enabled CKD Platform
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
The ready-to-use kits provide broad serotype coverage, standardized reagents, and simplified workflows for laboratories measuring adeno-associated virus capsids.
The new platform offers three-tiered approach to help laboratories at different stages of data maturity extract actionable insights from operational data.
Study of 177 patients with limited-stage small cell lung cancer demonstrates ctDNA's potential to personalize consolidation immunotherapy decisions.